Lukas Bunse
@lukasbunse.bsky.social
Neurologist and Immunologist at University Heidelberg and DKFZ with a focus on immunotherapy and cellular therapy of brain tumors and CNS autoimmunity
Reposted by Lukas Bunse
For his investigations how the body's own immune system can be supported in fighting brain tumors, Lukas Bunse (DKFZ & University Medical Centre Mannheim) has been awarded the Lautenschläger Prize for Young Scientists. 👏
@lukasbunse.bsky.social
t1p.de/4w2f5
@lukasbunse.bsky.social
t1p.de/4w2f5
Lautenschläger Prize for Young Scientists 2025 awarded to Lukas Bunse
As a clinician scientist at the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of Heidelberg University, neurologist Lukas Bunse is investigating how the body's own immune syste...
t1p.de
December 1, 2025 at 9:08 AM
For his investigations how the body's own immune system can be supported in fighting brain tumors, Lukas Bunse (DKFZ & University Medical Centre Mannheim) has been awarded the Lautenschläger Prize for Young Scientists. 👏
@lukasbunse.bsky.social
t1p.de/4w2f5
@lukasbunse.bsky.social
t1p.de/4w2f5
Reposted by Lukas Bunse
The immunology of brain tumors | Science Immunology www.science.org/doi/10.1126/...
Happy to share this review article by @lukasbunse.bsky.social, Theresa Bunse and I @platten-lab.bsky.social, Michael Kilian, Fran Quintana @quintanalabhms.bsky.social.
Happy to share this review article by @lukasbunse.bsky.social, Theresa Bunse and I @platten-lab.bsky.social, Michael Kilian, Fran Quintana @quintanalabhms.bsky.social.
The immunology of brain tumors
The cellular and molecular determinants of the antigenicity of brain tumors and the immunosuppressive brain tumor microenvironment are reviewed.
www.science.org
October 4, 2025 at 10:49 AM
The immunology of brain tumors | Science Immunology www.science.org/doi/10.1126/...
Happy to share this review article by @lukasbunse.bsky.social, Theresa Bunse and I @platten-lab.bsky.social, Michael Kilian, Fran Quintana @quintanalabhms.bsky.social.
Happy to share this review article by @lukasbunse.bsky.social, Theresa Bunse and I @platten-lab.bsky.social, Michael Kilian, Fran Quintana @quintanalabhms.bsky.social.
Reposted by Lukas Bunse
Our CIMT coverage is out!
👉 Go to bit.ly/3SUQCOX to read a summary of select talks. #CIMT2025 Featured are: @ki.se @unileiden.bsky.social @ethz.ch @niaidnews.bsky.social @dkfz.bsky.social @lukasbunse.bsky.social @biontech.bsky.social
👉 Go to bit.ly/3SUQCOX to read a summary of select talks. #CIMT2025 Featured are: @ki.se @unileiden.bsky.social @ethz.ch @niaidnews.bsky.social @dkfz.bsky.social @lukasbunse.bsky.social @biontech.bsky.social
May 28, 2025 at 8:00 PM
Our CIMT coverage is out!
👉 Go to bit.ly/3SUQCOX to read a summary of select talks. #CIMT2025 Featured are: @ki.se @unileiden.bsky.social @ethz.ch @niaidnews.bsky.social @dkfz.bsky.social @lukasbunse.bsky.social @biontech.bsky.social
👉 Go to bit.ly/3SUQCOX to read a summary of select talks. #CIMT2025 Featured are: @ki.se @unileiden.bsky.social @ethz.ch @niaidnews.bsky.social @dkfz.bsky.social @lukasbunse.bsky.social @biontech.bsky.social
Reposted by Lukas Bunse
Herzlichen Glückwunsch:
🏆️ Juniorprofessor Dr. Peter Andre @peterandre.bsky.social , #Wirtschaftspolitik, @safefrankfurt.bsky.social @goetheuni.bsky.social
🏆️ Dr. Lukas Bunse
@lukasbunse.bsky.social, #Neurologie, Universitätsmedizin Mannheim, Universität Mannheim 2/6
🏆️ Juniorprofessor Dr. Peter Andre @peterandre.bsky.social , #Wirtschaftspolitik, @safefrankfurt.bsky.social @goetheuni.bsky.social
🏆️ Dr. Lukas Bunse
@lukasbunse.bsky.social, #Neurologie, Universitätsmedizin Mannheim, Universität Mannheim 2/6
March 28, 2025 at 11:33 AM
Herzlichen Glückwunsch:
🏆️ Juniorprofessor Dr. Peter Andre @peterandre.bsky.social , #Wirtschaftspolitik, @safefrankfurt.bsky.social @goetheuni.bsky.social
🏆️ Dr. Lukas Bunse
@lukasbunse.bsky.social, #Neurologie, Universitätsmedizin Mannheim, Universität Mannheim 2/6
🏆️ Juniorprofessor Dr. Peter Andre @peterandre.bsky.social , #Wirtschaftspolitik, @safefrankfurt.bsky.social @goetheuni.bsky.social
🏆️ Dr. Lukas Bunse
@lukasbunse.bsky.social, #Neurologie, Universitätsmedizin Mannheim, Universität Mannheim 2/6
Reposted by Lukas Bunse
Huge congrats @lukasbunse.bsky.social, so well deserved, fantastic achievement.
@hlsalliance.bsky.social @cn-hd.bsky.social @neurooncologyhd.bsky.social @mctneuroscience.bsky.social @platten-lab.bsky.social
@hlsalliance.bsky.social @cn-hd.bsky.social @neurooncologyhd.bsky.social @mctneuroscience.bsky.social @platten-lab.bsky.social
Herzlichen Glückwunsch:
🏆️ Juniorprofessor Dr. Peter Andre @peterandre.bsky.social , #Wirtschaftspolitik, @safefrankfurt.bsky.social @goetheuni.bsky.social
🏆️ Dr. Lukas Bunse
@lukasbunse.bsky.social, #Neurologie, Universitätsmedizin Mannheim, Universität Mannheim 2/6
🏆️ Juniorprofessor Dr. Peter Andre @peterandre.bsky.social , #Wirtschaftspolitik, @safefrankfurt.bsky.social @goetheuni.bsky.social
🏆️ Dr. Lukas Bunse
@lukasbunse.bsky.social, #Neurologie, Universitätsmedizin Mannheim, Universität Mannheim 2/6
March 28, 2025 at 11:54 AM
Huge congrats @lukasbunse.bsky.social, so well deserved, fantastic achievement.
@hlsalliance.bsky.social @cn-hd.bsky.social @neurooncologyhd.bsky.social @mctneuroscience.bsky.social @platten-lab.bsky.social
@hlsalliance.bsky.social @cn-hd.bsky.social @neurooncologyhd.bsky.social @mctneuroscience.bsky.social @platten-lab.bsky.social
Reposted by Lukas Bunse
PTPRZ1 was upregulated in GBM samples and was associated with cell stemness (GSC score). [...] bit.ly/416M1wV @lukasbunse.bsky.social
February 25, 2025 at 1:00 PM
PTPRZ1 was upregulated in GBM samples and was associated with cell stemness (GSC score). [...] bit.ly/416M1wV @lukasbunse.bsky.social
Reposted by Lukas Bunse
Congratulations to David for being a finalist for the YPIC #proteomics Fund!
We are happy to support his application at the Immunopeptidomics Platform HI-TRON and hope the fund will make this breakthrough project possible in collab with David from @lukasbunse.bsky.social lab at @dkfz.bsky.social
We are happy to support his application at the Immunopeptidomics Platform HI-TRON and hope the fund will make this breakthrough project possible in collab with David from @lukasbunse.bsky.social lab at @dkfz.bsky.social
Meet YPIC Student Proteomics Fund finalist David Palmero
Cantón!
David is a biotechnologist by training who specialized in cancer research during his master’s studies and is now pursuing his PhD at DKFZ-German Cancer Research Center.
Cantón!
David is a biotechnologist by training who specialized in cancer research during his master’s studies and is now pursuing his PhD at DKFZ-German Cancer Research Center.
February 21, 2025 at 5:55 PM
Congratulations to David for being a finalist for the YPIC #proteomics Fund!
We are happy to support his application at the Immunopeptidomics Platform HI-TRON and hope the fund will make this breakthrough project possible in collab with David from @lukasbunse.bsky.social lab at @dkfz.bsky.social
We are happy to support his application at the Immunopeptidomics Platform HI-TRON and hope the fund will make this breakthrough project possible in collab with David from @lukasbunse.bsky.social lab at @dkfz.bsky.social
Reposted by Lukas Bunse
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen
www.nature.com/articles/s41...
@lukasbunse.bsky.social @naturecomms.bsky.social
www.nature.com/articles/s41...
@lukasbunse.bsky.social @naturecomms.bsky.social
February 2, 2025 at 5:37 PM
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen
www.nature.com/articles/s41...
@lukasbunse.bsky.social @naturecomms.bsky.social
www.nature.com/articles/s41...
@lukasbunse.bsky.social @naturecomms.bsky.social
1/2 Super excited to see this finally out @naturecomms.bsky.social ! We developed an off-the-shelf T cell receptor T cell therapy for patients with glioblastoma from a peptide vaccinated patient. Looking very much forward to its translation within DKTK supported by HI-TRON!
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen - Nature Communications
Vaccination in glioblastomas does lead to the emergence of tumour-antigen-specific T cells but T cell dysfunction, poor tumour infiltration and persistence hinder efficient tumour killing. Here author...
www.nature.com
February 2, 2025 at 9:08 PM
1/2 Super excited to see this finally out @naturecomms.bsky.social ! We developed an off-the-shelf T cell receptor T cell therapy for patients with glioblastoma from a peptide vaccinated patient. Looking very much forward to its translation within DKTK supported by HI-TRON!
Reposted by Lukas Bunse
Great fun to write this perspective with @lukasbunse.bsky.social @platten-lab.bsky.social @dkfz-iic.bsky.social @dkfz.bsky.social on a highly interesting study by the Bardeesy Lab. This study provides additional mechanistic rationale to combine IDH inhibitors with T cell activating therapies.
A recent study unpicks a key immune-mediated mechanism of mutant IDH–blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma. Learn more in a new Clinical Implications of Basic Research article: nej.md/4f3dIMf
#MedSky
#MedSky
Heating Up IDH-Mutant Gliomas | NEJM
A recent study unpicks a key immune-mediated mechanism of mutant IDH–blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma.
nej.md
December 11, 2024 at 5:45 PM
Great fun to write this perspective with @lukasbunse.bsky.social @platten-lab.bsky.social @dkfz-iic.bsky.social @dkfz.bsky.social on a highly interesting study by the Bardeesy Lab. This study provides additional mechanistic rationale to combine IDH inhibitors with T cell activating therapies.
Reposted by Lukas Bunse
Could not be any prouder. Stellar work, fantastic lecture - day to remember. Welcome to the faculty @lukasbunse.bsky.social.
Today we congratulate @lukasbunse.bsky.social for his successful dissertation and his inaugural lecture at umm Mannheim. Congratulations!!
November 29, 2024 at 6:58 PM
Could not be any prouder. Stellar work, fantastic lecture - day to remember. Welcome to the faculty @lukasbunse.bsky.social.